Published in J Biomed Mater Res A on February 26, 2014
Degradability, bioactivity, and osteogenesis of biocomposite scaffolds of lithium-containing mesoporous bioglass and mPEG-PLGA-b-PLL copolymer. Int J Nanomedicine (2015) 0.76
An update on the Application of Nanotechnology in Bone Tissue Engineering. Open Orthop J (2016) 0.75
A review of the biological response to ionic dissolution products from bioactive glasses and glass-ceramics. Biomaterials (2011) 2.44
45S5 Bioglass-derived glass-ceramic scaffolds for bone tissue engineering. Biomaterials (2005) 2.11
Characterisation of a soft elastomer poly(glycerol sebacate) designed to match the mechanical properties of myocardial tissue. Biomaterials (2008) 1.63
In vitro differentiation and in vivo mineralization of osteogenic cells derived from human embryonic stem cells. Tissue Eng (2004) 1.59
Bone tissue engineering therapeutics: controlled drug delivery in three-dimensional scaffolds. J R Soc Interface (2009) 1.39
Chondrogenic differentiation of human embryonic stem cells: the effect of the micro-environment. Tissue Eng (2006) 1.36
The use of murine embryonic stem cells, alginate encapsulation, and rotary microgravity bioreactor in bone tissue engineering. Biomaterials (2008) 1.30
Effect of bioactive glasses on angiogenesis: a review of in vitro and in vivo evidences. Tissue Eng Part B Rev (2010) 1.29
Metallic ions as therapeutic agents in tissue engineering scaffolds: an overview of their biological applications and strategies for new developments. J R Soc Interface (2011) 1.18
Myocardial tissue engineering. Br Med Bull (2008) 1.17
An elastomeric patch derived from poly(glycerol sebacate) for delivery of embryonic stem cells to the heart. Biomaterials (2010) 1.16
Polyhydroxyalkanoate (PHA)/inorganic phase composites for tissue engineering applications. Biomacromolecules (2006) 1.12
Osteochondral tissue engineering: scaffolds, stem cells and applications. J Cell Mol Med (2012) 1.08
Polyhydroxyalkanoates in Gram-positive bacteria: insights from the genera Bacillus and Streptomyces. Antonie Van Leeuwenhoek (2006) 1.07
Calcium phosphate-based composites as injectable bone substitute materials. J Biomed Mater Res B Appl Biomater (2010) 1.05
PDLLA/Bioglass composites for soft-tissue and hard-tissue engineering: an in vitro cell biology assessment. Biomaterials (2004) 1.02
Assessment of polyglycolic acid mesh and bioactive glass for soft-tissue engineering scaffolds. Biomaterials (2004) 1.02
In vitro biocompatibility of 45S5 Bioglass-derived glass-ceramic scaffolds coated with poly(3-hydroxybutyrate). J Tissue Eng Regen Med (2009) 0.99
Magnetic resonance imaging evaluation of remodeling by cardiac elastomeric tissue scaffold biomaterials in a rat model of myocardial infarction. Tissue Eng Part A (2010) 0.97
Effect of particle size on hydroxyapatite crystal-induced tumor necrosis factor alpha secretion by macrophages. Atherosclerosis (2007) 0.97
Comparison of nanoscale and microscale bioactive glass on the properties of P(3HB)/Bioglass composites. Biomaterials (2008) 0.96
The pro-angiogenic properties of multi-functional bioactive glass composite scaffolds. Biomaterials (2011) 0.94
Multi-functional P(3HB) microsphere/45S5 Bioglass-based composite scaffolds for bone tissue engineering. Acta Biomater (2010) 0.94
Processing and characterization of porous structures from chitosan and starch for tissue engineering scaffolds. Biomacromolecules (2006) 0.94
Biocompatibility and bone mineralization potential of 45S5 Bioglass-derived glass-ceramic scaffolds in chick embryos. Acta Biomater (2008) 0.93
Evaluation of human bone marrow stromal cell growth on biodegradable polymer/bioglass composites. Biochem Biophys Res Commun (2006) 0.93
Electrophoretic deposition of biological macromolecules, drugs, and cells. Biomacromolecules (2013) 0.93
Accelerated mineralization of dense collagen-nano bioactive glass hybrid gels increases scaffold stiffness and regulates osteoblastic function. Biomaterials (2011) 0.90
In vitro attachment of Staphylococcus epidermidis to surgical sutures with and without Ag-containing bioactive glass coating. J Biomater Appl (2004) 0.89
The determinants for the enzyme activity of human parvovirus B19 phospholipase A2 (PLA2) and its influence on cultured cells. PLoS One (2013) 0.88
Cancer research by means of tissue engineering--is there a rationale? J Cell Mol Med (2013) 0.88
Permeability evaluation of 45S5 Bioglass-based scaffolds for bone tissue engineering. J Biomech (2008) 0.88
Premature degradation of poly(alpha-hydroxyesters) during thermal processing of Bioglass-containing composites. Acta Biomater (2009) 0.86
In vitro and in vivo analysis of macroporous biodegradable poly(D,L-lactide-co-glycolide) scaffolds containing bioactive glass. J Biomed Mater Res A (2005) 0.86
Poly(3-hydroxybutyrate) multifunctional composite scaffolds for tissue engineering applications. Biomaterials (2010) 0.86
Evaluation of angiogenesis of bioactive glass in the arteriovenous loop model. Tissue Eng Part C Methods (2013) 0.86
Biomedical applications of polyhydroxyalkanoates: an overview of animal testing and in vivo responses. Expert Rev Med Devices (2006) 0.86
Surface functionalization of Bioglass-derived porous scaffolds. Acta Biomater (2007) 0.85
Gamma interferon-induced guanylate binding protein 1 is a novel actin cytoskeleton remodeling factor. Mol Cell Biol (2013) 0.85
Composite surgical sutures with bioactive glass coating. J Biomed Mater Res B Appl Biomater (2003) 0.85
Toughening and functionalization of bioactive ceramic and glass bone scaffolds by biopolymer coatings and infiltration: a review of the last 5 years. Expert Rev Med Devices (2014) 0.84
Bisphosphonate-based strategies for bone tissue engineering and orthopedic implants. Tissue Eng Part B Rev (2012) 0.84
Chitosan membranes containing micro or nano-size bioactive glass particles: evolution of biomineralization followed by in situ dynamic mechanical analysis. J Mech Behav Biomed Mater (2012) 0.84
Bone tissue engineering by using a combination of polymer/Bioglass composites with human adipose-derived stem cells. Cell Tissue Res (2014) 0.84
Bioactivity of degradable polymer sutures coated with bioactive glass. J Mater Sci Mater Med (2004) 0.84
45S5-Bioglass(®)-based 3D-scaffolds seeded with human adipose tissue-derived stem cells induce in vivo vascularization in the CAM angiogenesis assay. Tissue Eng Part A (2013) 0.83
Reinforcement of calcium phosphate cement with multi-walled carbon nanotubes and bovine serum albumin for injectable bone substitute applications. J Mech Behav Biomed Mater (2010) 0.83
Effect of nanoparticulate bioactive glass particles on bioactivity and cytocompatibility of poly(3-hydroxybutyrate) composites. J R Soc Interface (2009) 0.83
Osteogenic differentiation of human dental pulp stromal cells on 45S5 Bioglass® based scaffolds in vitro and in vivo. Tissue Eng Part A (2012) 0.82
A unified in vitro evaluation for apatite-forming ability of bioactive glasses and their variants. J Mater Sci Mater Med (2015) 0.82
Multiple drug delivery hydrogel system for spinal cord injury repair strategies. J Control Release (2011) 0.82
Strategies for the chemical and biological functionalization of scaffolds for cardiac tissue engineering: a review. J R Soc Interface (2015) 0.82
Characterisation of bioactive and resorbable polylactide/Bioglass composites by FTIR spectroscopic imaging. Biomaterials (2004) 0.81
Behavior of encapsulated MG-63 cells in RGD and gelatine-modified alginate hydrogels. Tissue Eng Part A (2014) 0.81
Evaluation of an alginate-gelatine crosslinked hydrogel for bioplotting. Biofabrication (2015) 0.81
Fabrication and characterization of biodegradable poly(3-hydroxybutyrate) composite containing bioglass. Biomacromolecules (2007) 0.81
A novel method for producing electron transparent films of interfaces between cells and biomaterials. J Mater Sci Mater Med (2007) 0.80
Copper-releasing, boron-containing bioactive glass-based scaffolds coated with alginate for bone tissue engineering. Acta Biomater (2011) 0.80
Matrix-assisted pulsed laser evaporation of poly(D,L-lactide) for biomedical applications: effect of near infrared radiation. J Biomed Opt (2008) 0.80
Composite polymer-bioceramic scaffolds with drug delivery capability for bone tissue engineering. Expert Opin Drug Deliv (2013) 0.80
Three-dimensional mineralization of dense nanofibrillar collagen-bioglass hybrid scaffolds. Biomacromolecules (2010) 0.80
Effect of substrate mechanics on cardiomyocyte maturation and growth. Tissue Eng Part B Rev (2014) 0.80
Assessment of cellular toxicity of TiO2 nanoparticles for cardiac tissue engineering applications. Nanotoxicology (2010) 0.80
High prevelance of human parvovirus infection in patients with malignant tumors. Oncol Lett (2012) 0.80
Biomimetic poly(glycerol sebacate) (PGS) membranes for cardiac patch application. Mater Sci Eng C Mater Biol Appl (2013) 0.80
Bioglass-based scaffolds with carbon nanotube coating for bone tissue engineering. J Mater Sci Mater Med (2009) 0.80
In vivo characterisation of a novel bioresorbable poly(lactide-co-glycolide) tubular foam scaffold for tissue engineering applications. J Mater Sci Mater Med (2004) 0.79
Characterization of carbon nanotube (MWCNT) containing P(3HB)/bioactive glass composites for tissue engineering applications. Acta Biomater (2009) 0.79
Tuning of cell-biomaterial anchorage for tissue regeneration. Adv Mater (2013) 0.79
Processing and bioactivity of 45S5 Bioglass(®)-graphene nanoplatelets composites. J Mater Sci Mater Med (2014) 0.79
Incorporation of vitamin E in poly(3hydroxybutyrate)/Bioglass composite films: effect on surface properties and cell attachment. J R Soc Interface (2008) 0.79
Bioactive glasses as carriers for bioactive molecules and therapeutic drugs: a review. J Mater Sci Mater Med (2012) 0.79
Isotopically modified nanoparticles for enhanced detection in bioaccumulation studies. Environ Sci Technol (2011) 0.79
Controlled delivery of gentamicin using poly(3-hydroxybutyrate) microspheres. Int J Mol Sci (2011) 0.78
Scaffolds for vascularized bone regeneration: advances and challenges. Expert Rev Med Devices (2012) 0.78
Thermal Characterizations of silver-containing bioactive glass-coated Sutures. J Biomater Appl (2005) 0.78
Evaluation of the antibacterial effects of vancomycin hydrochloride released from agar-gelatin-bioactive glass composites. Biomed Mater (2015) 0.78
Effect of nano-sized bioactive glass particles on the angiogenic properties of collagen based composites. J Mater Sci Mater Med (2013) 0.78
Poly-3-hydroxyoctanoate P(3HO), a medium chain length polyhydroxyalkanoate homopolymer from Pseudomonas mendocina. Biomacromolecules (2011) 0.78
Bioactive glass-based scaffolds for bone tissue engineering. Adv Biochem Eng Biotechnol (2012) 0.78
Osteogenic differentiation of umbilical cord and adipose derived stem cells onto highly porous 45S5 Bioglass®-based scaffolds. J Biomed Mater Res A (2014) 0.77
Formation and in vitro biocompatibility of biomimetic hydroxyapatite coatings on chemically treated carbon substrates. J Biomed Mater Res A (2013) 0.77
Cobalt-releasing 1393 bioactive glass-derived scaffolds for bone tissue engineering applications. ACS Appl Mater Interfaces (2014) 0.76